These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 5344299
21. Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C. Messiha FS, Hsu TH, Bianchine JR. J Clin Invest; 1972 Feb; 51(2):452-5. PubMed ID: 5009125 [Abstract] [Full Text] [Related]
22. [Treatment of Parkinson's disease: L-dopa or stereotaxic technics?]. Krayenbuhl H, Siegfried J. Neurochirurgie; 1970 Feb; 16(1):71-6. PubMed ID: 4911157 [No Abstract] [Full Text] [Related]
23. [Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?]. Gauthier G, de Ajuriaguerra J, Geissbuhler F, Simona B, Constantinidis J, Yanniotis G, Krassoievitch M, Eisenring JJ, Tissot R. Presse Med (1893); 1971 Jan 16; 79(3):91-2. PubMed ID: 5539694 [No Abstract] [Full Text] [Related]
27. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study]. Tissot R, de Ajuriaguerra J. Nouv Presse Med; 1973 Feb 03; 2(5):315-6. PubMed ID: 4686226 [No Abstract] [Full Text] [Related]
34. [Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination]. Campanella G, Pennetta R. Acta Neurol (Napoli); 1974 Feb 11; 29(3):252-63. PubMed ID: 4417098 [No Abstract] [Full Text] [Related]